Piffoux, M., Leary, A., Follana, P., Abdeddaim, C., Joly, F., Bin, S., Bonjour, M., Boulai, A., Callens, C., Villeneuve, L., Alexandre, M., Schwiertz, V., Freyer, G., Rodrigues, M., You, B. (2025). Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial. Nature Communications. https://doi.org/10.1038/s41467-025-56914-7